A 3-day randomized clinical trial to investigate the desensitizing properties of three dentifrices

J Periodontol. 2013 Nov;84(11):e65-73. doi: 10.1902/jop.2013.120697. Epub 2013 Mar 14.

Abstract

Background: The aim of the present study is to evaluate the relative abilities of three desensitizing dentifrices to provide rapid relief of dentin hypersensitivity (DH).

Methods: Using a double-mask, randomized design, three dentifrices: 1) containing 8% arginine and 1,450 ppm sodium monofluorophosphate; 2) containing 8% strontium acetate and 1,040 ppm sodium fluoride; and 3) containing 30% microaggregation of zinc-carbonate hydroxyapatite nanocrystals were compared after 3-day treatment. Participant's DH was evaluated at baseline and after 3 days using air-blast, tactile, cold water, and subjective tests.

Results: The final sample consisted of 85 individuals: 29 received the arginine-based dentifrice (group 1), 27 the strontium acetate-based dentifrice (group 2), and 29 the dentifrice based on zinc-carbonate hydroxyapatite (group 3). All dentifrices were mostly effective to reduce DH: the percentage of score reduction from baseline to 3 days was >30% for all tests (except for subjective test of group 2). The comparison among the three dentifrices showed that, after 3 days, there was an improvement in air-blast (mean percentage of reduction, 39.2% in group 1, 42.0% in group 2, and 39.2% in group 3), cold water (41.5%, 51.8%, and 50%), tactile (50.3%, 40.1%, and 33.8%), and subjective (33.1%, 17.4%, and 31.4%) test scores, with differences being significant for cold water and subjective tests. For air-blast and tactile tests, there were no significant differences across groups at 3 days. Moreover, no significant differences at any test were observed in a subset of patients that were followed up to 8 weeks: all dentifrices were all highly efficacious.

Conclusions: This study documents that the three tested dentifrices significantly reduced DH after 3-day treatment, supporting their use in clinical practice. To the best of the authors' knowledge, this is the first report documenting the rapid relief from DH of a zinc-carbonate hydroxyapatite dentifrice.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / therapeutic use
  • Adolescent
  • Adult
  • Aged
  • Air
  • Arginine / therapeutic use
  • Calcium Carbonate / therapeutic use
  • Carbonates / therapeutic use
  • Cold Temperature
  • Dentifrices / therapeutic use*
  • Dentin Desensitizing Agents / therapeutic use*
  • Double-Blind Method
  • Durapatite / therapeutic use
  • Female
  • Fluorides / therapeutic use
  • Follow-Up Studies
  • Food
  • Humans
  • Male
  • Middle Aged
  • Nanoparticles / chemistry
  • Pain Measurement
  • Phosphates / therapeutic use
  • Sodium Fluoride / therapeutic use
  • Strontium / therapeutic use
  • Touch
  • Treatment Outcome
  • Water
  • Young Adult
  • Zinc Compounds / therapeutic use

Substances

  • Acetates
  • Carbonates
  • Dentifrices
  • Dentin Desensitizing Agents
  • Phosphates
  • Zinc Compounds
  • pro-argin
  • Water
  • strontium acetate
  • Sodium Fluoride
  • Durapatite
  • Arginine
  • zinc carbonate
  • Calcium Carbonate
  • Fluorides
  • Strontium